IATI-Biomed presents best of life-sciencesMay. 26, 2016
Some 6,000 participants from 45 countries will take part in the 15th IATI-BIOMED 2016 Conference and Exhibition, which gets underway in Tel Aviv on May 24.
The May 24-26 conference serves as a meeting place for Israel’s healthcare industry with their colleagues from around the globe, as well as a prime spot for one-on-one meetings.
The three-day gathering covers a variety of biomedical fields including immuno-oncology, medical robotics, health IT, personalized medicine, cardiology, neurological disorders, translational research, as well as ‘new kids on the block’ microbiome, gene editing & gene therapy.
Among the speakers taking part in the event are Jay D. Kranzler, VP and Global Head, External R&D Innovation – Biotherapeutics and Strategic Investments, Pfizer; Dr. Marie Lindner, Global Program Head, Strategic Partnership Team, Novartis; Dr. Anthony (Tony) Muslin, Vice President, Head of Cardiovascular and Fibrosis, Sanofi; and Dr. Luisa Salter-Cid, Vice-President, Immunoscience, Bristol-Myers Squibb.
At the conference, Mayo Clinic is launching the Mayo Clinic Israeli Startups initiative, which will encourage collaboration among Israeli health care startup companies and Mayo Clinic to accelerate availability of medical innovations to the public. This initiative will also introduce Israeli health care technology to the US through the outreach and collaborations among physicians and scientists to advance the development of new discoveries for the benefit of patients everywhere.